We are one of the longest established managers in longevity, delivering consistent and stable returns. Our diverse and senior team has over twenty years' combined experience in managing longevity funds and developing innovative longevity products.

Our in depth knowledge of longevity as an asset class has enabled us to pioneer the use of synthetics and to understand the nature of the different products available in the market. Our strength is in knowing which synthetic product to use and to ensure we optimise the funds' total exposure to synthetics versus physical life settlements.

We have developed our own hybrid valuation technique which ensures sustainable results whilst providing equal treatment to investors thus avoiding the risks of overvaluing the assets over time.

We have over $400m in longevity funds under management spread across a variety of funds designed to cater to a diverse range of investment objectives and criteria.